The harmful effects of woodfire heater smoke are coming under increased scrutiny, with Asthma Australia calling for a national approach from governments to reduce the health impacts.
As climate change drives increased aeroallergen prevalence and more extreme weather, incidence of thunderstorm asthma could become more frequent and unpredictable.
Randomised controlled study shows that deployment of germicidal ultraviolet technology results in a significant reduction in the cumulative incidence in respiratory viral infections.
The latest edition of the Australian Asthma Handbook offers pathways to improvement for asthma control, urging clinicians and their patients to move beyond over-reliance on SABA inhalers in favour of inhaled corticosteroid (ICS)-containing preventer inhalers.
Successful trials of new medications offer hope for people with pulmonary fibrosis.
Spirometry testing is necessary for an accurate diagnosis of chronic obstructive pulmonary disease (COPD) and is a cornerstone of optimised COPD management. A new report from the Australian Commission on Safety and Quality in Health Care (the Commission) highlights that the people who need it most are missing out.
Monoclonal antibody therapies for severe asthma can reduce risky corticosteroid loads, but are still underutilised, writes clinical associate professor Debbie Rigby.
A national clinical care standard is set to improve outcomes and reduce potentially avoidable hospital admissions for the incurable lung condition, chronic obstructive pulmonary disease (COPD).
InSight+ spoke with Dr Brett Montgomery about a “win-win” solution to improve asthma control for thousands of Australians while helping reduce the climate impact of asthma inhalers
